Atlas Trials

Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults

Clinical trial NCT04723394 · COMPLETED

Trial details

NCT number
NCT04723394
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2021-01-28
Primary completion
2021-08-21
Enrollment
910

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.